Stephen W. Reese, MD
@sreese_uromd
SUO Urologic Oncology Fellow @UrologyMSK. Graduate of @bwhurology. Views expressed herein are my own.
ID: 1527682426784387075
20-05-2022 16:07:57
18 Tweet
72 Followers
76 Following
Looking forward to Alex rejoining our team. Thanks to CU for all the patients in Boston who will benefit from your teaching. Brigham and Women's Hospital Department of Urology
EV-103 Dose Esc/Cohort A Confirmed ORR after 9 cycles 73.3% with a 15.6% complete response rate. Median DOR 25.6 mo, median OS 26.1 mo. Cohort K coming Sep 12. Christopher Hoimes Thomas Flaig Shilpa Gupta Rana McKay, MD, FASCO Matt Milowsky Memorial Sloan Kettering Cancer Center Journal of Clinical Oncology bit.ly/3Trt1oi
Interested in learning more about the oldest and largest Society of Urologic Oncology fellowship? Come join us at our virtual open house Wednesday Nov 16th 7 pm EST. docs.google.com/forms/d/e/1FAI… (zoom link to follow)
JUST IN: Cytoreductive Nephrectomy for Metastatic RCC Treated with Immune Checkpoint Inhibitors or Targeted Therapy: The IMDC does it again ! #IMDC Daniel Heng with Talal El Zarif, MD Ziad Bakouny, MD, MSc Shaan Dudani et al in European Urology secure-web.cisco.com/1nOqqWr2rKW30O…
Characterization of patients undergoing consolidative nephrectomy after immunotherapy. Presented by Stephen Reese, MD MultiCare Health. #IKCSNA22 written coverage by Christopher Wallis (he/him/his) University of Toronto > bit.ly/3T2gm9P Kidney Cancer
Now published in Urologic Clinics by UrologyMSK Stephen Reese Sari Khaleel ari hakimi et al.: Current and future biomarkers in the management of renal cell carcinoma urologic.theclinics.com/article/S0094-…
Checkmate-914 (adjuvant nivo/ipi) vs placebo in high-risk Kidney Cancer is out in the The Lancet: the study is negative with no DFS/OS advantage. 33% disc. for toxicity could be the main culprit. Thank you for all the patients/families who believe in thelancet.com/journals/lance…
Great to see this amazing work from wonderful co-fellows. #GU23 Andrew Katims, MD MPH @Cgaffmd UrologyMSK
Now published in Cancers MDPI by UrologyMSK Lina Posada Calderon, Lennert Eismann, Stephen W Reese ari hakimi et al.: Advances in imaging-based biomarkers in renal cell carcinoma: A critical analysis of the current literature mdpi.com/2072-6694/15/2…
Excellent weekend getting a masterclass in TURBT with Bernie Bochner, MD. The practice models were truly unbelievable!@Olympus_Corp UrologyMSK Christopher Gaffney Andrew Katims, MD MPH Ali S Mouzannar | علي سمير Brian M. Shinder
Annual open surgical skills training program (Day 1) for UrologyMSK fellows finishing research year. Great hosts @hartfordhosp CESI center, urology and vasc surgery Tim Donahue Andrew Katims, MD MPH Kelly Pekala MD Brian M. Shinder Stephen W. Reese, MD Christopher Gaffney Ali Mouzannar
Institutional trends Brigham and Women's Hospital Department of Urology Brigham and Women's Faulkner Hospital for same-day robot-assisted radical prostatectomy #ProstateCancer ➡️Makes ~ 50% of our cases ➡️No increase in complications or readmissions ➡️May soon become standard practice Full article sciencedirect.com/science/articl…
Now published in Journal of Urology by UrologyMSK Stephen Reese Sari Khaleel Jonathan Coleman, Paul Russo ari hakimi et al. Prognostic factors for survival in patients undergoing surveillance after cytoreductive nephrectomy auajournals.org/doi/10.1097/JU…
Congrats to Mark Dawidek and Stephen W. Reese, MD on winning best poster for their work with radiologic predictors of pathologic response in post IO cytoreduction! #AUA24
Congratulations to our stellar class of 2024! Was a special day and even a more special night! Memorial Sloan Kettering Cancer Center
